Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here